Benzyl[1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate
![BK20BR | 518048-02-7 | Benzyl[1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate](https://qncdn.chemcd.cn/alchemypharm/AP11076.png "BK20BR | 518048-02-7 | Benzyl[1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate")
Catalog No.: BK20BR
CAS.RN：518048-02-7
Molecular Formula: C24H25FN4O5
Molecular Weight: 468.48 g/mol
Purity: NLT 98%
Intermediates of Raltegravir
| Catalog No. | Product Name | CAS |
|---|---|---|
| BA15TG | Raltegravir API | 518048-05-0 |
| BK3NV6 | Methyl 2-(2-(benzyloxycarbonylamino)propan-2-yl)-5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxylate | 519032-08-7 |
| BK20BR | Benzyl[1-[4-[[(4-fluorobenzyl)amino]carbonyl]-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]-1-methylethyl]carbamate | 518048-02-7 |
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
